Akwii, RG; Sajib, MS; Zahra, FT; Tullar, P; Zabet-Moghaddam, M; Zheng, Y; Silvio Gutkind, J; Doci, CL; Mikelis, CM.
Angiopoietin-2-induced lymphatic endothelial cell migration drives lymphangiogenesis via the β1 integrin-RhoA-formin axis.
Angiogenesis.
2022;
25:373-396.
Alavattam, KG; Maezawa, S; Andreassen, PR; Namekawa, SH.
Meiotic sex chromosome inactivation and the XY body: a phase separation hypothesis.
Cellular and Molecular Life Sciences.
2022;
79.
Amoah, A; Keller, A; Emini, R; Hoenicka, M; Liebold, A; Vollmer, A; Eiwen, K; Soller, K; Sakk, V; Zheng, Y; et al.
Aging of human hematopoietic stem cells is linked to changes in Cdc42 activity.
Haematologica.
2022;
107:393-402.
Aoyagi, Y; Hayashi, Y; Harada, Y; Choi, K; Matsunuma, N; Sadato, D; Maemoto, Y; Ito, A; Yanagi, S; Starczynowski, DT; et al.
Mitochondrial Fragmentation Triggers Ineffective Hematopoiesis in Myelodysplastic Syndromes.
Cancer Discovery.
2022;
12:250-269.
Azhar, M; Kincaid, Z; Kesarwani, M; Ahmed, A; Wunderlich, M; Latif, T; Starczynowski, D; Azam, M.
Momelotinib is a highly potent inhibitor of FLT3-mutant AML.
Blood Advances.
2022;
6:1186-1192.
Badar, T; Chlon, T.
Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms.
Current Hematologic Malignancy Reports.
2022.
Barreyro, L; Sampson, AM; Ishikawa, C; Hueneman, KM; Choi, K; Pujato, MA; Chutipongtanate, S; Wyder, M; Haffey, WD; O'Brien, E; et al.
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia.
Science Translational Medicine.
2022;
14.
Bartram, J; Filippi, MD.
The new metabolic needs of hematopoietic stem cells.
Current Opinion in Hematology.
2022;
29:188-193.
Bennett, J; Starczynowski, DT.
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies.
Current Opinion in Hematology.
2022;
29:8-19.
Boscolo, E; Pastura, P; Schrenk, S; Goines, J; Kang, R; Pillis, D; Malik, P; Le Cras, TD.
NRASQ61R mutation in human endothelial cells causes vascular malformations.
Angiogenesis.
2022;
25:331-342.
Cancelas, JA; Genthe, JR; Stolla, M; Rugg, N; Bailey, SL; Nestheide, S; Shaz, B; Mack, S; Schroeder, K; Anani, W; et al.
Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storage.
Transfusion.
2022;
62:1619-1629.
Cancelas, JA; Nestheide, S; Rugg, N; Eckerman, A; Macdonald, VW; Charles, ML; Markstrom, L; Atkinson, AJ; King, MR; Snyder, M; et al.
Characterization and first-in-human clinical dose-escalation safety evaluation of a next-gen human freeze-dried plasma.
Transfusion.
2022;
62:406-417.
Chihanga, T; Vicente-Muñoz, S; Ruiz-Torres, S; Pal, B; Sertorio, M; Andreassen, PR; Khoury, R; Mehta, P; Davies, SM; Lane, AN; et al.
Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia.
Cancers.
2022;
14.
Cram, JP; Wu, J; Coover, RA; Rizvi, TA; Chaney, KE; Ravindran, R; Cancelas, JA; Spinner, RJ; Ratner, N.
P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis.
eLife.
2022;
11.
Del Águila, Á; Adam, M; Ullom, K; Shaw, N; Qin, S; Ehrman, J; Nardini, D; Salomone, J; Gebelein, B; Lu, QR; et al.
Olig2 defines a subset of neural stem cells that produce specific olfactory bulb interneuron subtypes in the subventricular zone of adult mice.
Development (Cambridge).
2022;
149.
Ehrman, JM; Merchan-Sala, P; Ehrman, LA; Chen, B; Lim, HW; Waclaw, RR; Campbell, K.
Formation of the Mouse Internal Capsule and Cerebral Peduncle: A Pioneering Role for Striatonigral Axons as Revealed in Isl1 Conditional Mutants.
Journal of Neuroscience.
2022;
42:3344-3364.
Felker, S; Shrestha, A; Bailey, J; Pillis, DM; Siniard, D; Malik, P.
Differential CXCR4 expression on hematopoietic progenitor cells versus stem cells directs homing and engraftment.
JCI insight.
2022;
7.
Filippi, M.
Hungry Hematopoietic Stem Cells during Bacterial Infection: Fatty Acid for Food.
2022;
4.
Filippi, MD.
Asymmetric division: the choice of fate for huHSCs.
Blood.
2022;
139:1930-1932.
Fishman, H; Madiwale, S; Geron, I; Bari, V; Van Loocke, W; Kirschenbaum, Y; Ganmore, I; Kugler, E; Rein-Gil, A; Friedlander, G; et al.
ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells.
Blood.
2022;
139:399-412.
González-Muñoz, T; Kim, AR; Ratner, N; Peinado, H.
The Need for New Treatments Targeting MPNST: The Potential of Strategies Combining MEK Inhibitors with Antiangiogenic Agents.
Clinical Cancer Research.
2022;
28:3185-3195.
Govindarajah, V; Reynaud, D.
Role of the hematopoietic stem cells in immunological memory.
Current stem cell reports.
2022;
8:35-43.
Hater, N; Iwaniuk, KM; Leifeld, C; Grüten, P; Wiek, C; Raba, K; Zhang, F; Fischer, JC; Andreassen, PR; Hanenberg, H; et al.
Identification of new RAD51D-regulating microRNAs that also emerge as potent inhibitors of the Fanconi Anemia/homologous recombination pathways.
Human Molecular Genetics.
2022.
Hegde, S; Gasilina, A; Wunderlich, M; Lin, Y; Buchholzer, M; Krumbach, OH F; Akbarzadeh, M; Ahmadian, MR; Seibel, W; Zheng, Y; et al.
Inhibition of the RacGEF VAV3 by the small molecule IODVA1 impedes RAC signaling and overcomes resistance to tyrosine kinase inhibition in acute lymphoblastic leukemia.
Leukemia.
2022;
36:637-647.
Hegde, S; Zheng, Y; Cancelas, JA.
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis.
Current Opinion in Hematology.
2022.
Intisar, A; Shin, HY; Kim, W; Kang, HG; Kim, MY; Kim, YS; Cho, Y; Mo, YJ; Lim, H; Lee, S; et al.
Implantable Electroceutical Approach Improves Myelination by Restoring Membrane Integrity in a Mouse Model of Peripheral Demyelinating Neuropathy.
Advanced Science.
2022.
Javier, J; Hinge, A; Bartram, J; Xu, J; Filippi, MD.
Transforming growth factor-β signaling modifies the hematopoietic acute inflammatory response to drive bone marrow failure.
Haematologica.
2022;
107:1323-1334.
Jones, LQ M; Starczynowski, DT.
IKAROS and MENIN in synergy in AML.
2022;
3:528-529.
Kogiso, M; Qi, L; Du, Y; Braun, FK; Zhang, H; Huang, LF; Guo, L; Huang, Y; Teo, WY; Lindsay, H; et al.
Synergistic anti-tumor efficacy of mutant isocitrate dehydrogenase 1 inhibitor SYC-435 with standard therapy in patient-derived xenograft mouse models of glioma.
Translational Oncology.
2022;
18.
Koh, W; Malik, P; Whitehead, J; Morales, DL S; Hayes, D.
Successful use of veno-venous extracorporeal membrane oxygenation for acute chest syndrome in a child with sickle cell disease and SARS-CoV-2.
Pediatric Pulmonology.
2022;
57:1096-1099.
Lynch, DR; Stringham, EN; Zhang, B; Balbin-Cuesta, G; Curtis, BR; Palumbo, JS; Greineder, CF; Tourdot, BE.
Anchoring IgG-degrading enzymes to the surface of platelets selectively neutralizes antiplatelet antibodies.
Blood Advances.
2022;
6:4645-4656.
Mock, DM; Stowell, SR; Franco, RS; Kyosseva, SV; Nalbant, D; Schmidt, RL; Cress, GA; Strauss, RG; Cancelas, JA; von Goetz, M; et al.
Antibodies against biotin-labeled red blood cells can shorten posttransfusion survival.
Transfusion.
2022;
62:770-782.
Muhammad, B; Parks, LG; Komurov, K; Privette Vinnedge, LM.
Defective transcription elongation in human cancers imposes targetable proteotoxic vulnerability.
Translational Oncology.
2022;
16.
Muto, T; Guillamot, M; Yeung, J; Fang, J; Bennett, J; Nadorp, B; Lasry, A; Redondo, LZ; Choi, K; Gong, Y; et al.
TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity.
Cell Stem Cell.
2022;
29:298-314.e9.
Nalapareddy, K; Zheng, Y; Geiger, H.
Aging of intestinal stem cells.
Stem Cell Reports.
2022;
17:734-740.
Niederkorn, M; Ishikawa, C; M. Hueneman, K; Bartram, J; Stepanchick, E; R. Bennett, J; E. Culver-Cochran, A; Bolanos, LC; Uible, E; Choi, K; et al.
The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia.
Leukemia.
2022;
36:438-451.
Ohanian, M; Cancelas, JA; Davenport, R; Pullarkat, V; Hervig, T; Broome, C; Marek, K; Kelly, M; Gul, Z; Rugg, N; et al.
Freeze-dried platelets are a promising alternative in bleeding thrombocytopenic patients with hematological malignancies.
American Journal of Hematology.
2022;
97:256-266.
Rao, R; Han, R; Ogurek, S; Xue, C; Wu, LM; Zhang, L; Hu, J; Phoenix, TN; Waggoner, SN; Lu, QR.
Glioblastoma genetic drivers dictate the function of tumor-associated macrophages/microglia and responses to CSF1R inhibition.
Neuro-Oncology.
2022;
24:584-597.
Romano, LM; Seu, KG; Papoin, J; Muench, DE; Konstantinidis, D; Olsson, A; Schlum, K; Chetal, K; Chasis, JA; Mohandas, N; et al.
Erythroblastic islands foster granulopoiesis in parallel to terminal erythropoiesis.
Blood.
2022.
Rubinstein, JD; Jodele, S; Heyenbruch, D; Wilhelm, J; Thomas, S; Lutzko, C; Zhu, X; Leemhuis, T; Cancelas, JA; Keller, M; et al.
Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients.
Transplantation and cellular therapy.
2022;
28:116.e1-116.e7.
Rubinstein, JD; Lutzko, C; Leemhuis, T; Zhu, X; Pham, G; Ray, L; Thomas, S; Dourson, C; Wilhelm, J; Lane, A; et al.
Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant.
Blood Advances.
2022;
6:2897-2907.
Schrenk, S; Boscolo, E.
A transcription factor is the target of propranolol treatment in infantile hemangioma.
Journal of Clinical Investigation.
2022;
132.
Tirtakusuma, R; Szoltysek, K; Milne, P; Grinev, V; Ptasinska, A; Chin, PS; Meyer, C; Nakjang, S; Hehir-Kwa, JY; Williamson, D; et al.
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukaemia.
Blood.
2022.
Tu, Z; Fan, C; Davis, AK; Hu, M; Wang, C; Dandamudi, A; Seu, KG; Kalfa, TA; Lu, QR; Zheng, Y.
Autism-associated chromatin remodeler CHD8 regulates erythroblast cytokinesis and fine-tunes the balance of Rho GTPase signaling.
Cell Reports.
2022;
40.
Tu, Z; Zheng, Y.
Role of ATP-dependent chromatin remodelers in hematopoietic stem and progenitor cell maintenance.
Current Opinion in Hematology.
2022;
29:174-180.
Vogel, M; Möhrle, B; Sakk, V; Brown, A; Palmer, A; Braumüller, S; Huber-Lang, M; Allgöwer, A; Cancelas, JA; Geiger, H.
A Limited Role for AMD3100 Induced Stem Cell Mobilization for Modulation of Thoracic Trauma Outcome.
Shock.
2022;
57:260-267.
Xu, X; Zhang, C; Jiang, J; Xin, M; Hao, J.
Effect of TDP43-CTFs35 on Brain Endothelial Cell Functions in Cerebral Ischemic Injury.
Molecular Neurobiology.
2022;
59:4593-4611.
Yeaton, A; Cayanan, G; Loghavi, S; Dolgalev, I; Leddin, EM; Loo, CE; Torabifard, H; Nicolet, D; Wang, J; Corrigan, K; et al.
The impact of inflammation-induced tumor plasticity during myeloid transformation.
Cancer Discovery.
2022.
Yi, J; Kim, B; Shi, X; Zhan, X; Lu, QR; Xuan, Z; Wu, J.
PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma.
Cancer Research.
2022;
82:2874-2886.
Ying, L; Zhao, J; Ye, Y; Liu, Y; Xiao, B; Xue, T; Zhu, H; Wu, Y; He, J; Qin, S; et al.
Regulation of Cdc42 signaling by the dopamine D2 receptor in a mouse model of Parkinson's disease.
Aging Cell.
2022;
21.
Zhang, J; Guan, M; Zhou, X; Berry, K; He, X; Lu, QR.
Long Noncoding RNAs in CNS Myelination and Disease.
Neuroscientist.
2022.
Zhang, Z; Zhang, F; Davis, AK; Xin, M; Walz, G; Tian, W; Zheng, Y.
CDC42 controlled apical-basal polarity regulates intestinal stem cell to transit amplifying cell fate transition via YAP-EGF-mTOR signaling.
Cell Reports.
2022;
38.
Zhao, H; Lu, J; Yan, T; Han, F; Sun, J; Yin, X; Shen, C; Wunderlich, M; Yun, W; Yang, L; et al.
Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2.
Cell Reports.
2022;
38.